polycythemia vera

Polycythemia Vera ( PV ) is a clonal stem cell disease with yet unknown pathogenesis .

真性红细胞增多症（真红）系克隆性造血干细胞疾病，病因和发病机理不明。

Erythrocyte Separation Combined with Hydroxyurea and Interferon - α for Treatment of Polycythemia Vera

红细胞去除术联合羟基脲和α-干扰素治疗真性红细胞增多症疗效分析

Clinical Observation of Therapeutic Blood Cell Collection in Treatment of Polycythemia Vera

治疗性血细胞采集术治疗真性红细胞增多症的疗效观察

Extensive thrombosis in portal system with polycythemia vera : one case report

广泛门静脉血栓伴红细胞血红蛋白逐渐增高1例报道

Clinical Analysis of Cerebral Venous Sinus Thrombosis Secondary to Polycythemia Vera

真性红细胞增多症继发颅内静脉窦血栓形成两例临床分析

Cerebral vascular diseases in polycythemia vera patients : A retrospective analysis of 43 cases

真性红细胞增多症并发脑血管病43例临床分析

Treatment of polycythemia vera with homoharringtonine : report of 13 cases

高三尖杉酯碱治疗真性红细胞增多症13例报告

Expression of apoptosis related proteins in CD34 positive bone marrow cells of patients with polycythemia vera

真性红细胞增多症患者骨髓CD34阳性细胞凋亡相关蛋白的表达

They had experienced symptoms of polycythemia vera for an average of7 years .

他们平均已患有真性多血症的症状达7年之久。

Activating Blood Circulation and Removing Stasis in Treating Polycythemia Vera : Clinical Observation and Therapeutical Mechanism

活（破）血逐瘀法治疗真性红细胞增多症疗效观察及其机理探讨

The characteristically analyses of clinical manifestations of ocular disorders as first symptoms for polycythemia vera

以眼部症状为首发表现的真性红细胞增多症患者眼部临床特征分析

Diagnosis and Treatment of Polycythemia Vera

真性红细胞增多症的诊断与治疗

Objective To study the mechanism , clinical manifestations and pathophysiological characteristics of erythromelalgia accompanying polycythemia vera .

目的研究伴发于真性红细胞增多症的红斑性肢痛症发病机制、临床表现、病理生理特点。

To discuss epidermal growth factor receptor inhibitor for the potential targeted therapy of polycythemia vera . Methods : 1 .

探讨表皮生长因子受体抑制剂用于真性红细胞增多症靶向治疗的潜能。

Objective To analyze and explore the clinical manifestations of ocular disorders for polycythemia vera ( PV ) .

目的分析和探讨真性红细胞增多症患者眼部病变的临床特征。

Erythrocytapheresis in combination with drug treatment for polycythemia vera

红细胞单采术联合药物治疗真性红细胞增多症

Treatment of Polycythemia Vera Chiefly by Activating Blood Circulation and Nourishing Yin : A Clinical Observation of 10 Cases

活血养阴法为主治疗真性红细胞增多症10例临床观察

Analysis of the Expression of TCR V β Subfamily T Cells in Patients with Polycythemia Vera by RT-PCR

应用RT-PCR分析真性红细胞增多症病人TCRVβ亚家族T细胞的表达

The feature of T cell clonality with polycythemia vera

真性红细胞增多症患者T细胞的克隆特点

Objective : To explore the efficacy of erythrocytapheresis in polycythemia vera ( PV ) patients .

目的：探讨红细胞单采术在真性红细胞增多症（PV）治疗中的效果。

Objective To analyze the particularities of diagnosis and treatment of acute cerebral stroke secondary to polycythemia vera ( PV ) .

目的分析以脑卒中首发表现的真性红细胞增多症（PV）的诊断和治疗特点。

Influence of Blood - activating and Blood - stasis - removing Therapy on Cell Apoptosis and Expression of Associated Gene in Polycythemia Vera

活血祛瘀法对真性红细胞增多症细胞凋亡及相关基因表达的影响

Nursing of Hysteromyoma Combined with Polycythemia Vera in Peri-operation

子宫肌瘤合并真性红细胞增多症的围手术期护理

Probe in treatment of polycythemia vera ( PV ) by the radioactive nuclide ~ ( 32 ) P

放射性核素~（32）P治疗真性红细胞增多症的探讨

Objective : To evaluate the role of Interferon alpha ( IFN - α) in treatment of polycythemia vera ( PV ) .

目的：探讨干扰素α（IFN-α）治疗真性红细胞增多症（PV）的作用机制。

Objective To investigate the growth of endogenous erythroid colony ( EEC ) in polycythemia vera ( PV ) patients and its clinical significance .

目的了解真性红细胞增多症（PV）患者内源性红系集落（EEC）生长情况及其临床意义。

Polycythemia vera is a abnormal clone disease of hemopoietic stem cell , of which the characteristics is the increase of Hb and RBC .

真性红细胞增多症（PV）是发生于造血干细胞水平的异常克隆性疾病，以血红蛋白和红细胞数量增高为主要特征。

Objective : To observe the curative effect of activating blood circulation and nourishing yin ( ABNY ) for polycythemia vera ( PV ) .

目的：观察以活血养阴法为主治疗真性红细胞增多症（polycythemiavera，PV）的临床疗效。

BACKGROUD : Polycythemia vera ( PV ) is a malignant clonal hemotopoietic disorder resulted from the mutation of multipotent hematopoietic stem cells .

〖研究背景〗真性红细胞增多症（PV）是由于多潜能造血干细胞发生突变而引起的恶性克隆性疾病。

Conclusions The skew distribution and clonal expansion of TCR V β subfamily T cells in patients with polycythemia vera might be a feature of the immune response for malignant cells .

结论PV患者外周血TCRVβ亚家族的优势表达和克隆性增殖可能是患者体内对抗恶性细胞的免疫反应特征。